NasdaqGM - Delayed Quote USD

Entrada Therapeutics, Inc. (TRDA)

12.43 -0.46 (-3.57%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
129,013.00
129,013.00
--
--
--
Operating Expense
132,175.00
132,175.00
97,248.00
51,127.00
26,667.00
Operating Income
-3,162.00
-3,162.00
-97,248.00
-51,127.00
-26,667.00
Net Non Operating Interest Income Expense
15,218.00
15,218.00
2,632.00
-31.00
144.00
Pretax Income
12,056.00
12,056.00
-94,616.00
-51,158.00
-26,523.00
Tax Provision
18,741.00
18,741.00
--
--
--
Net Income Common Stockholders
-6,685.00
-6,685.00
-94,616.00
-51,158.00
-26,523.00
Diluted NI Available to Com Stockholders
-6,685.00
-6,685.00
-94,616.00
-51,158.00
-26,523.00
Basic EPS
-0.20
--
-3.02
-8.16
-1.30
Diluted EPS
-0.20
--
-3.02
-8.16
-1.30
Basic Average Shares
33,050.32
--
31,293.31
6,267.78
20,475.89
Diluted Average Shares
33,050.32
--
31,293.31
6,267.78
20,475.89
Total Operating Income as Reported
-3,162.00
-3,162.00
-97,248.00
-51,127.00
-26,667.00
Total Expenses
132,175.00
132,175.00
97,248.00
51,127.00
26,667.00
Net Income from Continuing & Discontinued Operation
-6,685.00
-6,685.00
-94,616.00
-51,158.00
-26,523.00
Normalized Income
-6,685.00
-6,685.00
-94,616.00
-51,158.00
-26,523.00
Interest Income
15,218.00
15,218.00
2,632.00
--
144.00
Net Interest Income
15,218.00
15,218.00
2,632.00
-31.00
144.00
EBIT
-3,162.00
-3,162.00
-97,248.00
-51,127.00
-26,667.00
EBITDA
-321.00
-321.00
-95,353.00
-50,010.00
-26,341.00
Reconciled Depreciation
2,841.00
2,841.00
1,895.00
1,117.00
326.00
Net Income from Continuing Operation Net Minority Interest
-6,685.00
-6,685.00
-94,616.00
-51,158.00
-26,523.00
Normalized EBITDA
-321.00
-321.00
-95,353.00
-50,010.00
-26,341.00
Tax Rate for Calcs
0.00
0.00
--
--
--
12/31/2020 - 10/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EWTX Edgewise Therapeutics, Inc.
16.11
+2.94%
 
TYRA Tyra Biosciences, Inc.
16.00
-2.32%
 
TCRX TScan Therapeutics, Inc.
7.38
+1.65%
 
HLVX HilleVax, Inc.
12.58
-1.80%
 
AVTE Aerovate Therapeutics, Inc.
21.20
-8.70%
 
TNGX Tango Therapeutics, Inc.
7.76
-0.13%
 
PEPG PepGen Inc.
11.83
+0.94%
 
PTGX Protagonist Therapeutics, Inc.
25.70
-4.28%
 
PRLD Prelude Therapeutics Incorporated
3.8700
0.00%
 
AURA Aura Biosciences, Inc.
7.10
-1.66%